Original filing (PDF)20250724101221NAL0005161249001

PALLEON PHARMACEUTICALS INC

Name: PALLEON PHARMACEUTICALS INC — Form 5500 (2024)
Creator: PALLEON PHARMACEUTICALS INC

Form 5500-SF

FILING_RECEIVED

401(k) retirement plan

Active participants

Accounts w/ balance

Plan assets (EOY)

$4.6M

Net assets (EOY)

$4.6M

Plan health score (directional)

/ 100

Grade A

Top-tier plan health

Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.

Compliance & disclosures

100

Concentration risk

Total plan cost

Vendor stack

100

Participation health

Decision-maker contacts

CFO / Head of HR / Benefits Manager — verified email + LinkedIn for PALLEON PHARMACEUTICALS INC.

Plan sponsor

Name

PALLEON PHARMACEUTICALS INC

EIN

47-4541546

Address

266 2ND AVENUE 2ND FLOOR · WALTHAM, MA · 02451

Phone

(857) 285-5913

Industry

Professional & Technical Servicessee all

Plan administrator

Same as plan sponsor.

Plan characteristics

Plan number

001

Plan year

2024

Plan year begin

2024-01-01

Tax period

2024-12-31

Filed

2025-07-24

Pension benefit codes

2E · Profit-sharing

2F · ERISA section 404(c)

2G · Total participant-directed accounts

2J · 401(k) feature

2K · 401(m) arrangement

2T · Default investment account (QDIA)

3D · Pre-approved plan (master / prototype / VS)

Audit & trust (Schedule H)

Service providers (Schedule C)

Small plans don't disclose service providers

Related plans

Similar-size Professional & Technical Services plans

RECLUDIX PHARMA, INC.

RECLUDIX PHARMA, INC. 401(K) PLAN

$4.6M · 52 participants

SURROZEN OPERATING, INC.

SURROZEN OPERATING, INC. 401K PLAN & TRUST

$4.6M · 41 participants

INTERNATIONAL BUDGET PARTNERSHIP

INTERNATIONAL BUDGET PARTNERSHIP 403(B) PLAN

$4.6M · 34 participants

REMIX THERAPUTICS INC.

REMIX THERAPEUTICS INC. 401(K) PLAN

$4.6M · 59 participants

APERIO CLINICAL OUTCOMES, LLC

APERIO CLINICAL OUTCOMES 401(K) PLAN